Skip to main content
SpringerLink
Log in

Radioprotectors and Chemoprotectors in the Management of Lung Cancer

  • Chapter
Advances in Radiation Oncology in Lung Cancer

Part of the book series: Medical Radiology Radiation Oncology ((Med Radiol Radiat Oncol))

  • 904 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Antonadou D, Coliarakis N, Synodinou M et al (2001) Randomized phase III trial of radiation treatment plus/minus amifostine in patients with advanced stage lung cancer. Int J Radiat Oncol Biol Phy 51:915–922

    Article  Google Scholar 

  • Antonadou D, Throuvalas N, Petridis A et al (2003) Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 57:402–408

    Article  PubMed  Google Scholar 

  • Bonner HS, Shaw LM (2002) New dosing regimens for amifostine: a pilot study to compare the relative bioavailability of oral and subcutaneous administration with intravenous infusion. J Clin Pharmacol 42:166–174

    Article  PubMed  Google Scholar 

  • Breuer R, Tochner Z, Conner MW et al (2000) Superoxide dismutase inhibits radiation-induced lung injury in hamsters. Lung 170:19–29

    Google Scholar 

  • Brizel DM (2003) Does amifostine have a role in chemoradiation treatment? Lancet Oncol 4:378–380

    Article  PubMed  Google Scholar 

  • Brizel DM, Wasserman TH, Henke M et al (2000) Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18:3339–3345

    PubMed  Google Scholar 

  • Calabro-Jones PM, Gahey RC, Smoluk GD et al (1985) Alkaline phosphatase promotes radioprotection and accumulation of WR-1065 in V79-171 cells incubated in medium containing WR-2721. Int J Radiat Biol 47:23–27

    Google Scholar 

  • Chopra M, Scott N, McMurray J et al (1989) A free radical scavenger. Br J Clin Pharmacol 27:396–399

    PubMed  Google Scholar 

  • Choy H, Milas L (2003) Enhancing radiotherapy with cyclooxy-genase-2 enzyme inhibitors: a rational advance? J Natl Cancer Inst 95:1440–1452

    PubMed  Google Scholar 

  • Curran WJ, Scott CB, Langer CJ et al (2003) Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410. Proc Am Sco Clin Oncol 22:621 (abstract 2499)

    Google Scholar 

  • Delanian S, Baillet F, Huart J et al (1994) Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: clinical trial. Radiother Oncol 32:12–20

    Article  PubMed  Google Scholar 

  • Dillman RO, Seagren SL, Propert KJ et al (1990) A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323:940–945

    PubMed  Google Scholar 

  • Dion MW, Hussey DH, Osborne JW (1989) The effect of pentoxifylline on early and late radiation injury following fractionated irradiation of C3H mice. Int J Radiat Oncol Biol Phys 17:101–107

    PubMed  Google Scholar 

  • Durand RE (1983) Radioprotection by WR-2721 in vitro and low oxygen tensions: Implications for its mechanisms of action. Br J Cancer 47:387–392

    PubMed  Google Scholar 

  • Durand RE, Olive PL (1989) Radiosensitization and radioprotection by BSO and WR-2721: the role of oxygenation. Br J Cancer 60:417–522

    Google Scholar 

  • Epperly MW, Bray JA, Krager S et al (1999) Intratracheal injectrion of adenovirus containing the human MnSOD transgene protects athymic nude mice from irradiation-induced organizing alveolitis. Int J Radiat Oncol Biol Phys 43:169–181

    Article  PubMed  Google Scholar 

  • Epperly MW, Gretton JA, DeFilippi SJ et al (2001) Modulation of radiation-induced cytokine elevation associated with esophagitis and esophageal stricture by manganese superoxide dismutase-plasmid/liposome (SOD2-PL) gene therapy. Radiat Res 155:2–14

    PubMed  Google Scholar 

  • Epperly MW, Guo HL, Jefferson M et al (2003) Cell phenotype specific kinetics of expression of intratracheally injected manganese superoxide dismutase plasmid/liposomes (MnSOD-PL) during lung radioprotective gene therapy. Gene Ther 2:163–171

    Article  Google Scholar 

  • Ferlay J, Bray F, Pisani P et al (2001) Cancer incidence, mortality and prevalence worldwide, Version 1.0 GLOBOCAN 2000. IARC cancer base no 5. IARC Press, Lyon

    Google Scholar 

  • Fuks Z, Persaud RS, Alfieri A et al (1994) Basic Fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res 54:2582–2590

    PubMed  Google Scholar 

  • Giannopoulou E, Papadimitriou E (2003) Amifostine has antiangiogenic properties in vitro by changing the redox status of human endothelial cells. Free Radic Res 37:1191–1199

    Article  PubMed  Google Scholar 

  • Gopal R, Cox JD, Liao Z et al (2002) Effects of amifostine on lung function in patients with non-small-cell lung cancer treated by radiation therapy and chemotherapy. In: Perez CA, Brady LW (eds) UPDATES: principles and practice of radiation oncology, vol 3(4), 3rd edn. Lippincott Williams and Wilkins, New York

    Google Scholar 

  • Graham NN, Evans ML, Dahlen DD et al (1988) Drug suppression of late radiation injury in the rat lung. 36th annual meeting of the Radiation Research Society, Philadelphia, 16–21 April

    Google Scholar 

  • Grdina DJ, Kataoka Y, Murley JS et al (2002) Inhibition of spontaneous metastases formation by amifostine. Int J Cancer 97:135–141

    Article  PubMed  Google Scholar 

  • Greenberger JS, Epperly MW, Gretton J et al (2003) Radioprotective gene therapy. Curr Gene Ther 3:183–195

    Article  PubMed  Google Scholar 

  • Guo H, Epperly MW, Bernarding M et al (2003) Manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) intratracheal gene therapy reduction of irradiation induced inflammatory cytokines does not protect orthotopic Lewis lung carcinomas. In Vivo 17:13–21

    PubMed  Google Scholar 

  • Haimovitz-Friedman A, Vlodavsky I, Chaudhuri A et al (1991) Autocrine effects of fibroblast growth factor in repair of radiation damage in endothelial cells. Cancer Res 51:2552

    PubMed  Google Scholar 

  • Hanson W (1998) Eicosanoid-induced radioprotection and chemoprotection: laboratory studies and clinical applications. In: Bump E, Malaker K (eds) Radioprotectors: chemical, biological and clinical perspectives. CRC Press, Boca Raton, pp 197–221

    Google Scholar 

  • Hunter N, Milas L (1983) Protection byS-2-(3-Aminopropyl-amino)-ethylphosphorothioic acid against radiation-induced leg contractures in mice. Cancer Res 43:1630–1632

    PubMed  Google Scholar 

  • Jemal A, Tiwari RC, Murray T et al (2004) Cancer statistics, 2004. CA Cancer J Clin 54:8–29

    PubMed  Google Scholar 

  • Kemp G, Rose P, Lurain J et al (1996) Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer. J Clin Oncol 14:2101–2112

    PubMed  Google Scholar 

  • Kirk-Othmer (1996) Encyclopedia of chemical technology, vol 20, 4th edn. Wiley, New York

    Google Scholar 

  • Kligerman MM, Turrisi AT, Urtasan RC et al (1988) Final report on Phase I trial of WR-2721 before protracted fractionated radiation therapy. Int J Radiat Oncol Biol Phys 14:1119–1122

    PubMed  Google Scholar 

  • Koh W-J, Stelzer KJ, Peterson LM, et al (1995) Effect of pentoxifyl-line on radiation-induced lung and skin toxicity in rats. Int J Radiat Oncol Biol Phys 31:71–77

    PubMed  Google Scholar 

  • Komaki R, Lee JS, Kaplan B, et al (2002a) Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results. Semin Radiat Oncol 12:46–49

    Article  PubMed  Google Scholar 

  • Komaki R, Seiferheld W, Ettinger D, et al (2002b) Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: Long-term follow-up of RTOG 92-04. Int J Radiat Oncol 53:548–557

    Article  Google Scholar 

  • Komaki R, Lee JS, Milas L, et al (2004) Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small cell lung cancer: report of a randomized comparative trial. Int J Radiat Oncol Biol Phy 58:1369–1377

    Article  Google Scholar 

  • Koukourakis MI, Kyrias G, Kakolyris S, et al (2000) Subcutaneous administration of amifostine during fractionated radiotherapy: A randomized Phase 11 Study. J Clin Oncol 18:2226–2233

    PubMed  Google Scholar 

  • Kwon HC, Kim SK, Chung WK et al (2000) Effect of pentoxifyl-line on radiation response of non-small cell lung cancer: a phase III randomized multicenter trial. Radiother Oncol 56:175–179

    Article  PubMed  Google Scholar 

  • LeChevalier T, Arriagada R, Quoix E, et al (1991) Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83:417–423

    PubMed  Google Scholar 

  • Lee I, Biaglow JE, Lee J et al (2000) Physiological mechanisms of radiation sensitization by pentoxifylline. Anticancer Res (6B):4605–4609

    Google Scholar 

  • Lefaix JL, Delanian S, Jean Jacques, et al (1999) Striking regression of subcutaneous fibrosis induced by high doses of gamma rays using a combination of pentoxifylline and a-tocopherol: an experimental study. Int J Radiat Oncol Biol Phys 43:839–847

    Article  PubMed  Google Scholar 

  • Leong SS, Tan EH, Fong KW, et al (2003) Randomized double-blind trial of combined modality treatment with or without amifostine in unresectable stage III non-small cell lung cancer. J Clin Oncol 21:1767–1774

    Article  PubMed  Google Scholar 

  • Lockhart SP (1990) Inhaled thiol and phosphothiol radioprotectors fail to protect the mouse lung. Radiother. Oncol. 19:187–191

    Article  PubMed  Google Scholar 

  • Michalowski AS (1994) On radiation damage to normal tissues and its treatment: II. Anti-inflammatory drugs. Acta Oncol. 33:139–157

    PubMed  Google Scholar 

  • Miki T, Bottaro DP, Fleming TP, et al (1992) Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA 89:246–250

    PubMed  Google Scholar 

  • Milas L (2001) Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse. Semin Radiat Oncol 11:290–299

    Article  PubMed  Google Scholar 

  • Milas L, Hanson WR (1995) Eicosanoids and radiation. Eur J Cancer 31A:1580–1585

    Article  PubMed  Google Scholar 

  • Milas L, Hunter N, Reid BO, et al (1982) Protective effects of S-2-(3-Aminopropylamino)-ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice. Cancer Res 42:1888–1897

    PubMed  Google Scholar 

  • Milas L, Murray D, Brock, VA, et al (1988) Radioprotectors in tumor radiotherapy: Factors and settings determining therapeutic ratio. Pharmacol Ther 30:179–187

    Article  Google Scholar 

  • Milas L, Nishiguchi I, Hunter N, et al (1992) Radiation protection against early and late effects of ionizing irradiation by the prostaglandin inhibitor indomethacin. Adv. Space Res. 12:265–271

    Article  Google Scholar 

  • Milas L, Mason KA, Liao Z, et al (2003a) Chemoradiotherapy: emerging treatment improvement strategies. Head and Neck 25:152–167

    Article  PubMed  Google Scholar 

  • Milas L, Mason K, Liao Z, et al (2003b) Role of Cyclooxygenase-2 (COX-2) and its inhibition in tumor biology and radiotherapy. In: Nieder C, Milas L, Ang KK (eds) Biological modification of radiation response: cytokines, growth factors and other biological targets. Springer-Verlag, Berlin Heidelberg New York, pp 241–258

    Google Scholar 

  • Moulder JE, Fish BL, Cohen EP (1993) Treatment of radiation nephropathy with ACE inhibitors. Int J Radat Oncol Biol Phys 27:93–99

    Google Scholar 

  • Movsas B, Scott C, Langer C, et al (2003) Phase III study of amifostine in patients with locally advanced NSCLC receiving chemotherapy and hyperfractionated radiation: RTOG 98-01. Proc Am Soc Clin Oncol 22:636

    Google Scholar 

  • Murray D, McBride WH (1996) Radioprotective agents. In: Kirk-Othmer Encyclopedia of Chemical Technology, 4th ed, vol. 20, pp 963–1006

    Google Scholar 

  • National Cancer Institute. Cancer. Gov. Non-small celllung cancer (PGQ): treatment. Health professional version, June 2002

    Google Scholar 

  • Nieder C, Jermic B, Astner S, et al (2003) Radiotherapy-induced lung toxicity: Risk factors and prevention strategies. Anticancer Res 23:4991–4998

    PubMed  Google Scholar 

  • Ohnishi ST, Ohnishi T, Glick JH, et al (1992) In vitro study on the antioxidant activities of Amifostine (WR-2721). Proc Amer Assoc Cancer Res 33:419 (2503A)

    Google Scholar 

  • Ozturk B, Egehan I, Atavci S et al (2004) Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: a double-blind randomized trial. Int I Radiat Oncol Biol Phys 58:213–219

    Google Scholar 

  • Panos RJ, Rubin JS, Aaronson SA, et al (1993) Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium. J Clin Invest 92:969–977

    PubMed  Google Scholar 

  • Petkau A (1987) Role of superoxide dismutase in modification of radiation injury. Brit J Cancer 55(Suppl VIII):87–95

    Google Scholar 

  • Rasey JS, Krohn KA, Menard TW, et al (1986) Comparative biodistribution and radioprotection studies with three radioprotective drugs in mouse tumors. Intl J Radiat Oncol Biol Phys 12:1487–1490

    Google Scholar 

  • Rasey JS, Grunbaum Z, Krohn KA, et al (1985) Biodistribution of the radioprotective drug 35S-labeled 3-amino-2-hydroxypropyl phosphorothioate (WR77913). Radiat Res 102:130–137

    PubMed  Google Scholar 

  • Redlich CA, Gao X, Rockwell S et al (1996) IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J Immunol 157:1705–1710

    PubMed  Google Scholar 

  • Roberts NA and Robinson PA (1995) Copper chelates of anti-rheumatic and anti-inflammatory agents and their super-oxide dismutase-like activity and stability. Br J Rheumatol 24:128–136

    Google Scholar 

  • Rube CE, Wilfert F, Uthe D et al (2002) Modulation of radiation-induced tumour necrosis factor alpha (TNF-alpha) expression in the lung tissue by pentoxifylline. Radiother Oncol 64:177–187

    Article  PubMed  Google Scholar 

  • Rubin JS, Osada H, Finch PW, et al (1989) Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA

    Google Scholar 

  • Savoye C, Swenberg C, Hugot S (1997) Thiol WR-1065 and disulphide WR-33278, two metabolities of the drug ethyol (WR-2721), protect DNA against fast neutron-induced strand breakage. Int J Radiat Biol 71:193–202

    Article  PubMed  Google Scholar 

  • Schaake-Koning C, van den Bogaert W, Dalesio O, et al (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl I Med 326:524–530

    Google Scholar 

  • Schuchter LM and Glick J (1993) The current status of WR-2721 (Amifostine): A chemotherapy and radiation therapy protector. J. Clin. Oncol 14: 3112–3120

    Google Scholar 

  • Senzer N (2002) A phase III randomized evaluation of amifostine in stage IIIA/IIIB non-small cell lung cancer patients receiving concurrent carboplatin, paclitaxel, and radiation therapy followed by gemcitabine and cisplatin intensification: preliminary findings. Semin Oncol 29:38–41

    Article  Google Scholar 

  • Shaw LM, Bonner H, Lieberman R (1999a) Pharmacokinetic profile of amifostine. Sem Oncol 23:18–22

    Google Scholar 

  • Shaw LM, Bonner HS, Schuchter L, et al (1999b) Pharmacokinetcs of Amifostine: Effects of doses and method of administration. Semin Oncol 26(2 Suppl 7):34–36

    Google Scholar 

  • Tee PG and Travis EL (1995) Basic fibroblast growth factor does not protect against classical radiation pneumonitis in two strains of mice. Cancer Res 55:298–302

    PubMed  Google Scholar 

  • Terry NHA, Brinkely J, Doig AJ, et al (2004) Cellular kinetics of murine lung: model system to determine basis for radioprotection with keratinocyte growth factor. Int J Radiat Oncol Biol Phys 58:435–444

    Article  PubMed  Google Scholar 

  • Travis E (1984) The oxygen dependence of protection by aminothiols: implications for normal tissues and solid tumors. Int J Radiat Oncol Biol Phys 10:1495–1501

    PubMed  Google Scholar 

  • Travis EL, Thames HD, Jr, Tucker SL, et al (1985) Late functional and biochemical changes in mouse lung after irradiation: Differential effects of WR-2721. Rad Res 103:219–231

    Google Scholar 

  • Ulich TR, Yi ES, Longmuir K, et al (1994) Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo J Clin Invest 93:1298–1306

    PubMed  Google Scholar 

  • Utley JF, Seaver N, Newton GL, et al (1984) Pharmacokinetics of WR-1065 in mouse tissue following treatment with WR-2721. Int J Radiat Oncol Biol Phys 10:1525–1528

    PubMed  Google Scholar 

  • Vujaskovic Z, Feng Q, Rabbani ZN, et al (2002a) Assessment of the protective effect of amifostine on radiation-induced pulmonary toxicity. Exp Lung Res 28:577–590

    Article  PubMed  Google Scholar 

  • Vujaskovic Z, Feng Q, Rabbani ZN, et al (2002b) Radioprotection of lungs by amifostine is associated with reduction in profibrogenic cytokine activity. Radiat Res 157:656–660

    PubMed  Google Scholar 

  • Wang LW, Fu XL, Clough R, et al (2000) Can angiotensin-converting enzyme inhibitors protect against symptomatic radiation pneumonitis? Radiat Res 153:405–410

    PubMed  Google Scholar 

  • Ward HE, Kemsley L, Davies L, et al (1992a) The effect of steroids on radiation-induced lung disease in the rat. Radiat Res 136:22–28

    Google Scholar 

  • Ward WF, Kim YT, Molteni A, et al (1988) Radiation-induced pulmonary endothelial dysfunction in rats: Modification by an inhibitor of angiotensin converting enzyme. Int J Radiat Oncol Biol Phys 15:135–140

    PubMed  Google Scholar 

  • Ward WF, Molteni A, Ts'ao C, et al (1990a) Captopril reduces collagen and mast cell accumulation in irradiated rat lung. Int J Radiat Oncol Biol Phys 19:1405–1409

    PubMed  Google Scholar 

  • Ward WF, Molteni A, Ts'ao C, et al (1990b) The effect of captopril on benign and malignant reactions in irradiated rat skin. Br J Radiol 63:349–354

    PubMed  Google Scholar 

  • Ward WF, Molteni A, Ts'ao C, et al (1992c) Radiation pneumotoxicity in rats: Modification by inhibitors of angiotensin converting enzyme. Int J Radiat Oncol Biol Phys 22:623–625

    PubMed  Google Scholar 

  • Ward WF, Kim YT, Molteni A, et al. (1992b) Pentoxifylline does not spare acute radiation reactions in rat lung and skin. Radiat Res 129:107–111

    PubMed  Google Scholar 

  • Ward WF, Lin PP, Wong PS, et al (1993) Radiation pneumonitis in rats and its modification by the angiotensin-converting enzyme inhibitor captopril evaluated by high resolution computer tomography. Radiat Res 135:81–87

    PubMed  Google Scholar 

  • Wasserman TH, Phillips TL, Ross G, et al (1981) Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs by WR-2721. Cancer Clin Trials 4:3–6

    PubMed  Google Scholar 

  • Yarom R, Harper IS, Wynchangk, et al. (1993) Effect of captopril on changes in rat's hearts induced by long-term irradiation. Radat Res 133:187–197

    Google Scholar 

  • Yi ES, Williams ST, Lee H, et al (1996) Keratinocyte growth factor ameliorates radiation-and bleomycin-induced lung injury and mortality. Am J Pathol 149:1963–1970

    PubMed  Google Scholar 

  • Yoon S, Park J, Jang H, Bahk Y and Shinn K. (1994) Radioprotective effect of captopril on the mouse jejunal mucosa. Int J Radiat Oncol Biol Phys 30:873–878

    PubMed  Google Scholar 

  • Yuhas JM (1980) Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-Aminopropylamino)-ethylphosphorothioic acid. Cancer Res 40:1519–1524

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA

    Ritsuko Komaki MD (Professor of Radiation Oncology), Joe Chang MD, PhD, Zhongxing Liao MD, James D. Cox MD, K. A. Mason MSc & Luka Milas MD, PhD

Authors
  1. Ritsuko Komaki MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joe Chang MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhongxing Liao MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. James D. Cox MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. A. Mason MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Luka Milas MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Str. 226, 81657, München, Germany

    Branislav Jeremić MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Komaki, R., Chang, J., Liao, Z., Cox, J.D., Mason, K.A., Milas, L. (2005). Radioprotectors and Chemoprotectors in the Management of Lung Cancer. In: Jeremić, B. (eds) Advances in Radiation Oncology in Lung Cancer. Medical Radiology Radiation Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26632-1_10

Download citation

  • DOI: https://doi.org/10.1007/3-540-26632-1_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-00522-3

  • Online ISBN: 978-3-540-26632-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation